Comments

ACADIA Pharmaceuticals

Q: What sector and industry does ACADIA Pharmaceuticals (ACAD) operate in?

ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ACADNASDAQ

ACADIA Pharmaceuticals (ACAD) Forecast

News Earnings ACADIA Pharmaceuticals (ACAD) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Quotes, Forecast and News Summary

ACADIA Pharmaceuticals Stock (NASDAQ: ACAD) stock price, news, charts, stock research, profile.

Open	$17.14
Close	-
Volume / Avg.	399.68K / 1.34M
Day Range	$16.37 - $17.30
52 Wk Range	14.15 - 32.59
Market Cap	$2.77B
P/E Ratio	21.82
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	7.77%
Days to Cover	9.14

Recent News

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

Neurogene (NASDAQ:NGNE) stock just took a sharp dive, plummeting 44% in a single day. Bad news on Monday caused the pharmaceutical company’s shares to drop massively in after-hours trading, and they continued to

MarketBeat

What's Going On With ACADIA Pharmaceuticals Stock?

ACADIA Pharmaceuticals shares are trading lower by 4.6% during Tuesday's session. The company appointed Catherine Owen Adams as CEO.

Henry Khederian

Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods

Cramer gives his take on E.l.f Beauty, Acadia Pharmaceuticals, B&G Foods, Lucid, SoFi, Dell, Johnson & Johnson, UWM and Symbotic.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.14
Close	-
Volume / Avg.	399.68K / 1.34M
Day Range	$16.37 - $17.30
52 Wk Range	14.15 - 32.59
Market Cap	$2.77B
P/E Ratio	21.82
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	7.77%
Days to Cover	9.14

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ACADIA Pharmaceuticals (ACAD) stock?

You can purchase shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) through any online brokerage.

View our list of the best stock brokerages

Who are ACADIA Pharmaceuticals (ACAD) competitors?

Other companies in ACADIA Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for ACADIA Pharmaceuticals (ACAD) stock?

ACADIA Pharmaceuticals has a consensus price target of $27.25.

What is the current price for ACADIA Pharmaceuticals (ACAD)?

The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $16.67 last updated November 15, 2024 at 12:00 PM EST.

Does ACADIA Pharmaceuticals (ACAD) pay a dividend?

There are no upcoming dividends for ACADIA Pharmaceuticals.

When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?

ACADIA Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is ACADIA Pharmaceuticals (ACAD) going to split?

There is no upcoming split for ACADIA Pharmaceuticals.

What sector and industry does ACADIA Pharmaceuticals (ACAD) operate in?

ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.